Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J2794 |
Short Description | Inj risperdal consta, 0.5 mg |
Long Description | Injection, risperidone (risperdal consta), 0.5 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2019-10-01 |
Date Added | 2005-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
50458030611 | J2794 | Inj risperdal consta, 0.5 mg | Risperdal Consta | JANSSEN PHARMACEUTICALS, INC. | 0.5 MG | 1 | 1 | 50 | 50 |
50458030711 | J2794 | Inj risperdal consta, 0.5 mg | Risperdal Consta | JANSSEN PHARMACEUTICALS, INC. | 0.5 MG | 1 | 1 | 75 | 75 |
50458030811 | J2794 | Inj risperdal consta, 0.5 mg | Risperdal Consta | JANSSEN PHARMACEUTICALS, INC. | 0.5 MG | 1 | 1 | 100 | 100 |
50458030911 | J2794 | Inj risperdal consta, 0.5 mg | Risperdal Consta | JANSSEN PHARMACEUTICALS, INC. | 0.5 MG | 1 | 1 | 25 | 25 |
Drug Details
-
Risperidone extended-release injection (Perseris, Risperdal Consta, Rykindo) is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection (Risperdal Consta, Rykindo) is used alone or in combination with lithium (Lithobid) or valproate to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.